[http://dx.doi.org/10.1111/j.1469-0691.2005.01082]
[http://dx.doi.org/10.1093/infdis/jix326]
[http://dx.doi.org/10.1111/1469-0691.1275]
Infectious Disorders - Drug Targets
Title:COVID-19 and Infectious Disease Speciality - A Necessity of Time in India
Volume: 22 Issue: 2
Author(s): Gopal K. Bohra, Deepak Kumar*Mahendra K. Garg
Affiliation:
- Department of Medicine, All India Institute of Medical Sciences Jodhpur, India
Export Options
About this article
Cite this article as:
Bohra K. Gopal, Kumar Deepak*, Garg K. Mahendra, COVID-19 and Infectious Disease Speciality - A Necessity of Time in India, Infectious Disorders - Drug Targets 2022; 22 (2) : e170322191976 . https://dx.doi.org/10.2174/1871526521666210302155650
DOI https://dx.doi.org/10.2174/1871526521666210302155650 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
Coronaviruses Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital
Infectious Disorders - Drug Targets Touting Traditional Knowledge and Herbal Medicine to Combat and Prevent COVID-19
Current Pharmaceutical Biotechnology Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment
Current HIV Research A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19)
Infectious Disorders - Drug Targets Update of QSAR & Docking Studies of the GSK-3 Inhibitors
Current Bioinformatics Is There Any Role of IL-6 Inhibition in COVID-19?
Coronaviruses How to Measure the Similarity Between Protein Ligand-Binding Sites?
Current Computer-Aided Drug Design Proteomic and Bioinformatics Tools to Understand Virulence Mechanisms in Staphylococcus aureus
Current Proteomics A Comparative Study of SARS, MERS with COVID-19
Coronaviruses High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies
Coronaviruses Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Current Molecular Medicine Molecular Recognition of Human Angiotensin-Coverting Enzyme I (hACE I) and Different Inhibitors
Current Topics in Medicinal Chemistry Trypsin-Chymotrypsin Inhibitors from Vigna mungo Seeds
Protein & Peptide Letters Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
Current Rheumatology Reviews Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion
Infectious Disorders - Drug Targets Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus
Letters in Drug Design & Discovery Pleiotropic Effects of Nitric Oxide on SARS-CoV-2 Infections
Coronaviruses Structure, Transmission, Diagnostic Symptoms, Host and Entry Mechanism of COVID-19: A Review
Coronaviruses